Correlation Between Neuropace and MaxCyte
Can any of the company-specific risk be diversified away by investing in both Neuropace and MaxCyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and MaxCyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and MaxCyte, you can compare the effects of market volatilities on Neuropace and MaxCyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of MaxCyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and MaxCyte.
Diversification Opportunities for Neuropace and MaxCyte
Very good diversification
The 3 months correlation between Neuropace and MaxCyte is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and MaxCyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MaxCyte and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with MaxCyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MaxCyte has no effect on the direction of Neuropace i.e., Neuropace and MaxCyte go up and down completely randomly.
Pair Corralation between Neuropace and MaxCyte
Given the investment horizon of 90 days Neuropace is expected to generate 1.97 times more return on investment than MaxCyte. However, Neuropace is 1.97 times more volatile than MaxCyte. It trades about 0.29 of its potential returns per unit of risk. MaxCyte is currently generating about 0.0 per unit of risk. If you would invest 649.00 in Neuropace on August 30, 2024 and sell it today you would earn a total of 371.00 from holding Neuropace or generate 57.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neuropace vs. MaxCyte
Performance |
| Timeline |
| Neuropace |
| MaxCyte |
Neuropace and MaxCyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neuropace and MaxCyte
The main advantage of trading using opposite Neuropace and MaxCyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, MaxCyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MaxCyte will offset losses from the drop in MaxCyte's long position.| Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics | Neuropace vs. Paragon 28 |
| MaxCyte vs. ReShape Lifesciences | MaxCyte vs. Bone Biologics Corp | MaxCyte vs. Tivic Health Systems | MaxCyte vs. Nuwellis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |